Partners

Our partners drive what we build

We work with institutions that share our commitment to rigorous science, regulatory integrity, and patient-centered innovation. Each partnership extends our capabilities across research, distribution, and product development.

Digital Health

Evidena

Digital health platform for patients and physicians — connecting pharmacies, clinics and patients in Switzerland.

Academic

ZHAW Zurich University of Applied Sciences

Joint pilot project for the regulated dispensing of recreational cannabis in Graubünden — bridging academic research with real-world regulatory frameworks.

Research

Autismus Schweiz

Collaboration on CBD-based therapeutic research for autism spectrum disorders, advancing evidence-based treatment approaches in Switzerland.

Distribution

GSI Creos Corporation

Exclusive partnership with the Tokyo-listed group for the distribution of CBD products for human and veterinary use across the Japanese market.

Academic

CEMS

Global alliance of leading business schools and multinational companies for management education and research.

Research

Prague University of Economics and Business

International research project on the economic viability of medical cannabis compared to conventional medicine.

Healthcare

Medical Village

Network for medical professionals and innovative healthcare solutions.

Analytics

Canexis

Specialised partner for cannabis analytics and quality assurance.

Pharma

Pharma Village

Platform for pharmaceutical innovation and collaboration.

Pharmacy

Swiss Bio Pharma

Swiss pharmaceutical partner for the development and distribution of biological medicines.